Artara Therapeutics Inc (TARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,294 | -10,755 | -47,252 | -37,024 | -26,247 |
| Depreciation Amortization | 865 | 466 | 2,904 | 1,343 | 1,235 |
| Other Working Capital | -1,476 | -2,551 | -516 | -368 | -2,120 |
| Other Operating Activity | 3,821 | 1,879 | 10,362 | 8,454 | 5,738 |
| Operating Cash Flow | $-16,084 | $-10,961 | $-34,502 | $-27,595 | $-21,394 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -14,428 | -12,415 | -124,748 | -115,959 | -99,574 |
| PPE Investments | -31 | -11 | -596 | -552 | -616 |
| Sale Of Investment | 28,706 | 13,171 | 27,150 | 16,428 | N/A |
| Investing Cash Flow | $14,247 | $745 | $-98,194 | $-100,083 | $-100,190 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -72 | -72 | -228 | -228 | -228 |
| Financing Cash Flow | $-72 | $-72 | $-228 | $-228 | $-228 |
| Beginning Cash Position | 36,469 | 36,469 | 169,393 | 169,393 | 169,393 |
| End Cash Position | 34,560 | 26,181 | 36,469 | 41,487 | 47,581 |
| Net Cash Flow | $-1,909 | $-10,288 | $-132,924 | $-127,906 | $-121,812 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,084 | -10,961 | -34,502 | -27,595 | -21,394 |
| Capital Expenditure | -31 | -11 | -596 | -552 | -616 |
| Free Cash Flow | -16,115 | -10,972 | -35,098 | -28,147 | -22,010 |